Paul Sakuma
FILE - In this June 30, 2010 file photo, a pharmacist holds a bottle of Avandia pills at Maximart Pharmacy in Palo Alto, Calif. Federal health officials say new patients should not be enrolled in a study of GlaxoSmithKline's controversial diabetes pill Avandia, after experts last week said the drug increases heart risks. (AP Photo/Paul Sakuma, file)
